跳至主要内容
临床试验/JPRN-jRCTs041210007
JPRN-jRCTs041210007进行中(未招募)2 期

A clinical study evaluating the effect of eppikajutsuto on lymphatic malformations - LMEP

Ogawa Keiko0 个研究点目标入组 20 人开始时间: 2021年4月16日最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 1. Diagunostic image (at least Echo,CT,MRI)demonstrates a specific LM lesion
  • 2. Weight 25kg or less

排除标准

  • When any one or more of the following items are satisfied
  • Has a history of allergic reactions to Eppikajutsuto.
  • Have received or have received mTOR inhibitors
  • Has undergone sclerotherapy / surgery in the past
  • Has a serious disease other than lymphatic malformation
  • Participated in other clinical studies (studies) within 3 months before the start of administration of the test drug
  • Evaluable MRI cannot be taken
  • When the principal investigator or the investigator determines that apatients is inappropriate for this study

研究者

发起方
Ogawa Keiko

相似试验